BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7776856)

  • 1. Mannan-binding protein and complement dependent opsonization in alcoholic cirrhosis.
    Homann C; Garred P; Hasselqvist P; Graudal N; Thiel S; Thomsen AC
    Liver; 1995 Feb; 15(1):39-44. PubMed ID: 7776856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.
    Super M; Levinsky RJ; Turner MW
    Clin Exp Immunol; 1990 Feb; 79(2):144-50. PubMed ID: 2311294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin.
    Gulati S; Sastry K; Jensenius JC; Rice PA; Ram S
    J Immunol; 2002 Apr; 168(8):4078-86. PubMed ID: 11937567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.
    Homann C; Varming K; Høgåsen K; Mollnes TE; Graudal N; Thomsen AC; Garred P
    Gut; 1997 Apr; 40(4):544-9. PubMed ID: 9176087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans.
    Valdimarsson H; Stefansson M; Vikingsdottir T; Arason GJ; Koch C; Thiel S; Jensenius JC
    Scand J Immunol; 1998 Aug; 48(2):116-23. PubMed ID: 9716101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.
    Kozel TR; MacGill RS; Percival A; Zhou Q
    Infect Immun; 2004 Jan; 72(1):209-18. PubMed ID: 14688098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assay for the mannan-binding lectin pathway of complement activation.
    Petersen SV; Thiel S; Jensen L; Steffensen R; Jensenius JC
    J Immunol Methods; 2001 Nov; 257(1-2):107-16. PubMed ID: 11687244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding.
    Brouwer N; Dolman KM; van Houdt M; Sta M; Roos D; Kuijpers TW
    J Immunol; 2008 Mar; 180(6):4124-32. PubMed ID: 18322223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IgA activates the complement system via the mannan-binding lectin pathway.
    Roos A; Bouwman LH; van Gijlswijk-Janssen DJ; Faber-Krol MC; Stahl GL; Daha MR
    J Immunol; 2001 Sep; 167(5):2861-8. PubMed ID: 11509633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein.
    Ohta M; Okada M; Yamashina I; Kawasaki T
    J Biol Chem; 1990 Feb; 265(4):1980-4. PubMed ID: 2298734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deficiency of mannan-binding protein--a recently discovered complement defect syndrome].
    Garred P; Thiel S; Madsen HO; Ryder LP; Jensenius JC; Svejgaard A
    Ugeskr Laeger; 1993 Jan; 155(1):25-9. PubMed ID: 8421844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.
    Jönsson G; Lood C; Gullstrand B; Holmström E; Selander B; Braconier JH; Sturfelt G; Bengtsson AA; Truedsson L
    Clin Immunol; 2012 Sep; 144(3):214-27. PubMed ID: 22842196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.
    Neth O; Jack DL; Johnson M; Klein NJ; Turner MW
    J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein.
    Green PJ; Feizi T; Stoll MS; Thiel S; Prescott A; McConville MJ
    Mol Biochem Parasitol; 1994 Aug; 66(2):319-28. PubMed ID: 7808481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of serum concentration on opsonization by the classical and alternative complement pathways.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1980 Feb; 27(2):693-6. PubMed ID: 6991425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.
    Yeaman GR; Kerr MA
    Clin Exp Immunol; 1987 Apr; 68(1):200-8. PubMed ID: 3308208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aspects of collectins and receptors for collectins.
    Hansen S; Holmskov U
    Immunobiology; 1998 Aug; 199(2):165-89. PubMed ID: 9777404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans.
    Ohta M; Kawasaki T
    Glycoconj J; 1994 Aug; 11(4):304-8. PubMed ID: 7873926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.